CR
Crinetics
CRNX · NASDAQ
$84.95 -0.01% (-$0.01)
1M +1.03%
Market Cap $9.00B
P/E Ratio -
Div. Yield -
ROE 44.22%
Bulios Fair Price
$67.73
20.3% downside
Trenutna cena
$84.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CRNX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
3 /100
Expensive P/S 213.54x
P/B 7.55x
P/E N/A
Growth
98 /100
Growing Rev. growth 17.56%
Book val. growth 46.38%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 99.16%
Net margin 1,189.88%
FCF margin 1,008.58%
Quality
0 /100
Poor ROIC 43.99%
ROE 44.22%
Asset turnover 0.03x
Debt
100 /100
Low Debt/Equity 0.04x
Current ratio 15.57x
Int. coverage N/A
Stability
29 /100
Unstable Beta 0.13x
Rev. volatility 396.81%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
R. Scott Struthers
Employees
594
Headquarters
San Diego
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report